Predictions in Medicine 2021: What Might We Expect?
An intense 2020 may be behind us, but, this year seems likely to place the COVID-19 pandemic front and center again.
An intense 2020 may be behind us, but, this year seems likely to place the COVID-19 pandemic front and center again.
AvKARE says it is not aware of any patients being harmed by the recalled products
This week the FDA and the WHO have a back and forth over remdesivir; Who should get a COVID vaccine; Xolair and Hetlioz have approval expansions; And a novel neuroblastoma treatment gets accelerated approval.
The approval was based on data from a 9-week, double-blind, placebo-controlled, crossover study which assessed the effects of Hetlioz in patients with SMS.
Nuplazid is approved for the treatment of hallucinations and delusions associated with Parkinson disease psychosis.
Younger patients and those with alopecia have significant disproportionality signals for increased suicidality
The study, which was fully remote and contactless, aimed to evaluate whether early treatment with fluvoxamine reduced the likelihood of clinical deterioration and disease severity in patients with mild COVID-19 illness.
While the CRL did not raise clinical concerns, the Agency noted that certain conditions related to the tablet coating process needed to be resolved.
The review included a total of 81 unique trials that reported 1 or more outcomes of interest.
NightWare is a smartwatch application that uses the Apple Watch and Apple iPhone platform.